The egg shortage and its effect on prices aren't doing the company any favors. It recently imposed surcharges on the many meals it makes with the protein, but these levies aren't universal. For ...

Nasdaq futures rose 0.4%. However, the high growth, tech heavy Nasdaq tumbled 4% into correction territory this week. The S&P shed. 3.6% over the last four days and closed at its lowest point since ...

The S&P 500 tumbled 1.8% to resume its slide after a mini-recovery from the prior day clawed back some of its sharp drop over recent weeks. The Dow Jones Industrial Average dropped 427 points ...

After soaring following the election, Tesla (NASDAQ: TSLA) stock ran into a wall in February as a number of news items, macro challenges, and CEO Elon Musk's involvement in the Department of ...

NEW YORK (AP) — U.S. stocks tumbled Monday and wiped out even more of their gains since President Donald Trump ’s election in November, after he said that tariffs announced earlier on Canada ...

Shares of online learning platform company Nerdy (NYSE: NRDY) fell hard today after the company reported its fourth-quarter results yesterday. While sales and earnings beat Wall Street's consensus ...

New Zealand's new deal with Vietnam, citizen arrest laws to be eased and international tourist spending on the rise. A teenager who pulled apart a scuffle at the Dunedin bus hub described the ...

Leveraged funds, promising two times the daily performance of Nvidia Corp., Tesla Inc., Amazon.com Inc. have tumbled. Triple-leveraged bets on innovation and semiconductor stocks have slid 20%.

Hims and Hers' stock fell over 19% in after-hours trading on Monday after its CEO said the company would no longer sell compounded versions of mega-hit weight loss drugs. "We will have to start ...

An icon in the shape of a lightning bolt. Impact Link Tesla sales in Europe plunged in January, falling 45% compared with the same month last year, while overall sales of electric vehicles ...

Hims and Hers plans to stop selling compounded weight loss drugs after an FDA update. Hims and Hers' stock fell over 19% in after-hours trading on Monday. The FDA removed semaglutide injections ...